The advent of novel nonsteroidal mineralocorticoid receptor antagonists in heart failure

Media formats available:

Clinical implications of the evidence from IV iron trials in HF
Clinical implications of the evidence from IV iron trials in HF
Heart Failure
Clinical implications of the evidence from IV iron trials in HF
- Stefan D. Anker, MD, PhD
- Robert J. Mentz, MD, FHFSA, FACC, FAHA
- Piotr Ponikowski, MD, PhD, FESC, FHFA
New diagnostic strategy to improve early CVD diagnosis in primary care patients with COPD or T2D
New diagnostic strategy to improve early CVD diagnosis in primary care patients with COPD or T2D
ESC Congress 2023
New diagnostic strategy to improve early CVD diagnosis in primary care patients with COPD or T2D
- Amy Groenewegen, MD
Management of patients with CKD and HF complicated by hyperkalemia
Management of patients with CKD and HF complicated by hyperkalemia
Kidney Disease
Management of patients with CKD and HF complicated by hyperkalemia
- Ellie Kelepouris, MD
- Stephen J. Greene, MD
What is the totality of evidence for IV iron treatment outcomes in patients with HF?
What is the totality of evidence for IV iron treatment outcomes in patients with HF?
Heart Failure
What is the totality of evidence for IV iron treatment outcomes in patients with HF?
- Giuseppe M.C. Rosano, MD, PhD
- Antoni Bayés-Genís, MD, PhD
- Ovidiu Chioncel, MD, PhD

PACE-CME